‘Pre-cachexia’: a non-existing phenomenon in cancer?
Open Access
- 14 May 2014
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 25 (8) , 1668-1669
Abstract
We read with great interest the article by Blum et al. [1] who reported an important validation study on the diagnostic framework of cancer cachexia. For patients with cancer, cachexia is a major problem associated with reduced physical functioning [2], tolerance to anti-cancer therapy [3] and survival [2]. Despite the growing knowledge on the pathophysiology of cachexia, assessment in clinical practice is limited due to lack of adequate diagnostic criteria. The past years, experts developed a diagnostic framework [4] but validation studies were still awaited. Blum et al. reported that differentiation of cachexia from no cachexia using the proposed framework worked out successfully with significant and clinically relevant differences in laboratory values, food intake, performance status and survival [1].Keywords
This publication has 5 references indexed in Scilit:
- Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model—a study based on data from an international multicentre project (EPCRC-CSA)Annals of Oncology, 2014
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Consensus definition of sarcopenia, cachexia and pre-cachexia: Joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”Clinical Nutrition, 2010
- Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosisThe American Journal of Clinical Nutrition, 2006
- Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?European Journal of Cancer, 1998